Deep Tide TechFlow News, on July 8th, according to CoinDesk, brokerage Benchmark has given Semler Scientific a 'Buy' rating and set its stock target price at $101. Analyst Mark Palmer expressed optimism about the company's transition from the medical diagnostics field to a Bitcoin reserve strategy, as the company has acquired approximately 4,636 Bitcoins for $430 million, with an average cost basis of $92,753 per Bitcoin.